Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cope

Showing results (121-130 of 187) with videos related to

Pageof 19
Sort By:
Clinical and Experimental Immunology|January 1, 1995
A rare mediastinal tumour presenting with systemic effects due to IL-6 and tumour necrosis factor (TNF) productionK A Davies, A P Cope, J B Schofield, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 17, 2021
Epidemiology of Scleritis in the United Kingdom From 1997 to 2018: Population-Based Analysis of 11 Million Patients and Association Between Scleritis and Infectious and Immune-Mediated Inflammatory DiseaseTasanee Braithwaite, Nicola J Adderley, Anuradhaa Subramanian, et al.
Rheumatology (Oxford, England)|October 3, 2017
Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis-a proof of principle and exploratory trial: is dose tapering practical in good responders?Fowzia Ibrahim, Beatriz Lorente-Cánovas, Caroline J Doré, et al.
Pulmonary Pharmacology & Therapeutics|May 2, 2021
Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-19Marie Fisk, Magnus Althage, Sven Moosmang, et al.
The Journal of Rheumatology|May 17, 2015
Do Genetic Susceptibility Variants Associate with Disease Severity in Early Active Rheumatoid Arthritis?Ian C Scott, Frühling Rijsdijk, Jemma Walker, et al.
Rheumatology (Oxford, England)|May 18, 2021
A systematic review and network meta-analysis of the safety of early interventional treatments in rheumatoid arthritisMaryam A Adas, Victoria B Allen, Mark Yates, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 26, 1999
Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motifA E Herman, R M Tisch, S D Patel, et al.
Nature Protocols|November 18, 2016
A Bayesian cluster analysis method for single-molecule localization microscopy dataJuliette Griffié, Michael Shannon, Claire L Bromley, et al.
Annals of the Rheumatic Diseases|May 10, 2025
Time-independent disease state identification defines distinct trajectories determined by localised vs systemic inflammation in patients with early rheumatoid arthritisNils Steinz, Tjardo D Maarseveen, Erik B van den Akker, et al.
Environmental Monitoring and Assessment|April 12, 2018
Monitoring spatial and temporal variation of dissolved oxygen and water temperature in the Savannah River using a sensor networkChristopher J Post, Michael P Cope, Patrick D Gerard, et al.
Pageof 19

Showing results (121-130 of 187) with videos related to

Sort By:
Pageof 19
Clinical and Experimental Immunology|January 1, 1995
A rare mediastinal tumour presenting with systemic effects due to IL-6 and tumour necrosis factor (TNF) productionK A Davies, A P Cope, J B Schofield, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 17, 2021
Epidemiology of Scleritis in the United Kingdom From 1997 to 2018: Population-Based Analysis of 11 Million Patients and Association Between Scleritis and Infectious and Immune-Mediated Inflammatory DiseaseTasanee Braithwaite, Nicola J Adderley, Anuradhaa Subramanian, et al.
Rheumatology (Oxford, England)|October 3, 2017
Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis-a proof of principle and exploratory trial: is dose tapering practical in good responders?Fowzia Ibrahim, Beatriz Lorente-Cánovas, Caroline J Doré, et al.
Pulmonary Pharmacology & Therapeutics|May 2, 2021
Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-19Marie Fisk, Magnus Althage, Sven Moosmang, et al.
The Journal of Rheumatology|May 17, 2015
Do Genetic Susceptibility Variants Associate with Disease Severity in Early Active Rheumatoid Arthritis?Ian C Scott, Frühling Rijsdijk, Jemma Walker, et al.
Rheumatology (Oxford, England)|May 18, 2021
A systematic review and network meta-analysis of the safety of early interventional treatments in rheumatoid arthritisMaryam A Adas, Victoria B Allen, Mark Yates, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 26, 1999
Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motifA E Herman, R M Tisch, S D Patel, et al.
Nature Protocols|November 18, 2016
A Bayesian cluster analysis method for single-molecule localization microscopy dataJuliette Griffié, Michael Shannon, Claire L Bromley, et al.
Annals of the Rheumatic Diseases|May 10, 2025
Time-independent disease state identification defines distinct trajectories determined by localised vs systemic inflammation in patients with early rheumatoid arthritisNils Steinz, Tjardo D Maarseveen, Erik B van den Akker, et al.
Environmental Monitoring and Assessment|April 12, 2018
Monitoring spatial and temporal variation of dissolved oxygen and water temperature in the Savannah River using a sensor networkChristopher J Post, Michael P Cope, Patrick D Gerard, et al.
Pageof 19